Concepedia

Annie Frimm

AF

Statistics

Publications

6

Citations

748

H-Index

6

Active since

2008

Affiliations

Siga Technologies (United States)(Current)

INC Research (United States)

Orlando Clinical Research Center

Annie Frimm is an author at Siga Technologies (United States) specializing in pharmacy, antiviral therapy, and antiviral pharmacology.

Publications per year

2008–2018

6

Publications

6

Oral Tecovirimat for the Treatment of Smallpox

Douglas W. Grosenbach, Kady M. Honeychurch, Eric A. Rose et al. · New England Journal of Medicine · 2018 · 416 citations · Full text

, , +13

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Robert Jordan, Arthur J. Goff, Annie Frimm et al. · Antimicrobial Agents and Chemotherapy · 2009 · 136 citations · Full text

, , +17

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

Robert Jordan, Deborah Tien, Tové C. Bolken et al. · Antimicrobial Agents and Chemotherapy · 2008 · 71 citations · Full text

, , +10

Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects

Robert Jordan, Jarasvech Chinsangaram, Tové C. Bolken et al. · Antimicrobial Agents and Chemotherapy · 2010 · 54 citations · Full text

, , +15

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt et al. · Antimicrobial Agents and Chemotherapy · 2012 · 52 citations · Full text

, , +12

1–5 of 6